NEBULA
Vandœuvre-lès-Nancy, France
NEBULA is a CNRS/Lorraine University spin-out TechBio offering high-valued services and expertise to the pharma/biotech industry thanks to its physics-driven generative AI drug discovery engine capable of (1) modeling the full dynamics of any therapeutic target, (2) identifying druggable binding sites, often cryptic or allosteric and inaccessible by other methods, and (3) designing in silico innovative and transformative drug-candidates with optimized profiles.
Company Info
- Founded
- 2024
- Website
- nebulabio.tech/
Only accessible to MedStartr community members.
Join nowWhat do you think of NEBULA?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.